Accessibility Menu

Injective Protocol

(CRYPTO) INJ

Current Price$4.99
Market Cap$498.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)+562%
5 Year-23%
1 Year-62%
1 Month-8%
Injective Protocol last closing stock price
MetricPriceDate
Last closeUSD 5.082026-07-15
Injective Protocol stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+7.95%USD 4.712026-07-08
1 month-8.43%USD 5.552026-06-15
3 month+49.06%USD 3.412026-04-16
Year to date+12.21%USD 4.532026-01-01
1 year-62.07%USD 13.402025-07-15
3 year-42.96%USD 8.912023-07-16
5 year-22.69%USD 6.572021-07-16
Since inception+561.71%USD 0.772020-10-20

Injective Protocol Financials at a Glance

Market Cap

$498.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$4.99

Volume

93,207,304

Open

$5.08

Previous Close

$0.00

Daily Range

$4.96 - $5.20

52-Week Range

$2.73 - $16.45

Estimated Earnings Date

N/A

INJ News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Injective Protocol

Injective is a layer-1 blockchain designed for decentralised finance, offering pre-built modules and interoperability for advanced financial applications. INJ, its native token, supports governance, staking, and transaction fees. Developed by Injective Labs, the platform also integrates AI capabilities for autonomous and data-driven applications.

Industry

Consumer Finance

INJ Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$498.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

93.21M

Avg. Volume

0

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,531.75-0.01%
^DJIDJI
$52,488.88-0.00%
^IXICNASDAQ
$25,933.85-0.01%
BTCBitcoin
$64,171.00-0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$15.60-0.00%
ATAIAtaiBeckley
$7.15+0.33%
NOKNokia
$10.38-0.08%
ONDSOndas
$6.65-0.06%

Questions About INJ

What is the current price of Injective Protocol?

Injective Protocol is trading at $4.99 per share.

What is the 52-week range for Injective Protocol?

Over the past 52 weeks, Injective Protocol has traded between $2.73 and $16.45.

How much debt does Injective Protocol have?

Injective Protocol total debt is unavailable.

How much cash does Injective Protocol have on hand?

Injective Protocol does not have cash on hand data available.

What is Injective Protocol’s dividend yield?

Injective Protocol does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.